Cited by 1,203Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk FactorsDiabetes Management and Research

The DOI matches its Crossref record.

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

Kannel, W B, McGee, D L·1979·Diabetes Care

DOI 10.2337/diacare.2.2.120

Open this paper in CoChat — free account

Abstract

This report examines prospectively, in the Framingham cohort, the relation of diabetes and impaired glucose tolerance to each of the cardiovascular sequelae, taking into account age, sex, and associated cardiovascular risk factors. The incidence of cardiovascular disease, as well as the levels of cardiovascular risk factors, were found to be higher in diabetic than in nondiabetic men and women. The relative impact of diabetes on coronary heart disease, peripheral vascular disease, or stroke incidence was the same in men and women, but for cardiovascular mortality and cardiac failure the impact is greater for women. Present evidence suggests that alleviation of associated cardiovascular risk factors is the most promising course in reducing cardiovascular sequelae in diabetic patients.

Integrity signals

Registry

Crossref · 10.2337/diacare.2.2.120

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sorted by citations

Items 601–700 of 999

Coronary and cerebrovascular atherosclerosis: two aspects of the same disease or two different pathologies?
Puddu, P., Puddu, G. M., Bastagli, L., Massarelli, G., & Muscari, A. (1995) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(94)00600-c · Cited by 17
Evaluation of risk factors for cardiovascular diseases among Saudi diabetic patients attending primary health care service
Ahmed, A. A., Alsharief, E., & Alsharief, A. (2013) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2013.06.012 · Cited by 15
New approach to diabetes care: From blood glucose to cardiovascular disease
Aguíar, C., Duarte, R., & Carvalho, D. M. (2019) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2019.01.001 · Cited by 15
Cardiac SNARE Expression in Health and Disease
Bowman, P. R. T., Smith, G. L., & Gould, G. W. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00881 · Cited by 16
“Cardiovascular disease has long been established to be a leading cause of death in the diabetic population, in part attributable to the high rate of vascular disease that occurs on account of sustained excessive glucose (and fat) in the bloodstream (4).”
Background
Association between Framingham risk score and subclinical atherosclerosis among elderly with both type 2 diabetes mellitus and healthy subjects.
Amer, M. S., Khater, M. S., Omar, O. H., et al. (2014) · PubMed · Cited by 15
Cardiovascular Disease Risk Factors Other than Dyslipidemia
Teramoto, T., Sasaki, J., Ishibashi, S., Birou, S., Daida, H., Dohi, S., Egusa, G., Hiro, T., Hirobe, K., Iida, M., et al. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.17368 · Cited by 16
High glucose enhances inducible nitric oxide synthase expression. Role of protein kinase C-βII
Pacheco, M., Beltrán, A. E., Redondo, J., et al. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.052 · Cited by 15
Cardiovascular Risk Profile in Mediterranean Patients Submitted to Bariatric Surgery and Intensive Lifestyle Intervention: Impact of Both Interventions After 1 Year of Follow-Up
Sanchís, P., Frances, C., Nicolau, J., Rivera, R., Fortuny, R., Julian, X., Pascual, S., Gómez, L. A., Rodrı́guez, I., Olivares, J., et al. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1321-z · Cited by 16
Analysis on the polymorphisms of site RS4977574, and RS1333045 in region 9p21 and the susceptibility of coronary heart disease in Chinese population
Hua, L., Yuan, J., He, S., Zhao, C., Jia, Q., Zhang, J., An, F., Chen, Z.-H., Li, L., Wang, L., et al. (2020) · BMC Medical Genetics · doi:10.1186/s12881-020-0965-x · Cited by 15
Renin-Angiotensin-Aldosterone System Blockade in Diabetes: Role of Direct Renin Inhibitors
Estacio, R. O. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.05.2000 · Cited by 15
Pancreatic β-cell function as a predictor of cardiovascular outcomes and costs: findings from the Cardiovascular Health Study
Curtis, L. H., Hammill, B. G., Bethel, M. A., Anstrom, K. J., Liao, L., Gottdiener, J. S., & Schul, K. A. (2007) · Current Medical Research and Opinion · doi:10.1185/030079908x253573 · Cited by 15
Recalculation of cardiovascular risk score as a surrogate marker of change in clinical care of diabetes patients: the Alphabet POEM project (Practice Of Evidence-based Medicine)
Lee, J. D., Morrissey, J., & Patel, V. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125003539 · Cited by 16
“© 2004 LIBRAPHARM LTD – Curr Med Res Opin 2004; 20(5) Cardiovascular risk score in diabetes patients Lee et al.”
BackgroundInfluential
Coronary Risk Factors: An Overview
Lloyd‐Jones, D. M., & Kannel, W. B. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_128 · Cited by 15
Self-citation
Treating the diabetic patient: appropriate care for glycemic control and cardiovascular disease risk factors.
ZARICH, S. W. (2003) · PubMed · Cited by 15
Cardiovascular implications of insulin resistance and non–insulin-dependent diabetes mellitus
McNulty, P. H., Ettinger, S. M., Gilchrist, I. C., Kozak, M., & Chambers, C. E. (2001) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/jcan.2001.28338 · Cited by 15
Lipoproteins as Predictors of Ischemic Heart Disease in Non-Insulin-Dependent Diabetic Men
Barrett-Connor, E. L., Philippi, T., & Khaw, K. (1987) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(18)31256-x · Cited by 15
Association of hypertension and dyslipidaemia with increasing obesity in patients with Type 2 Diabetes Mellitus
Saleem, Z., Saeed, H., Khan, Z. A., Khan, M. I., Hashmi, F. K., Islam, M. F., Bashir, A., & Sadeeqa, S. (2019) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902019000118136 · Cited by 14
Impact of Diabetes Mellitus on the Clinical Management of Global Cardiovascular Risk: Analysis of the Results of the Evaluation of Final Feasible Effect of Control Training and Ultra Sensitization (EFFECTUS) Educational Program
Tocci, G., Ferrucci, A., Guida, P., et al. (2011) · Clinical Cardiology · doi:10.1002/clc.20937 · Cited by 14
Recent Advances in Understanding the Pathogenesis of Cardiovascular Diseases and Development of Treatment Modalities
Mittal, R., Jhaveri, V. M., Kay, S.-I. S., Greer, A. B., Sutherland, K. J., McMurry, H. S., Lin, N., Mittal, J., Malhotra, A. K., & Patel, A. P. (2018) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x18666180508111353 · Cited by 14
Epigenome-Wide Histone Acetylation Changes in Peripheral Blood Mononuclear Cells in Patients with Type 2 Diabetes and Atherosclerotic Disease
Bompada, P., Gonçalves, I., Wu, C., Gao, R., Sun, J., Mir, B. A., Luan, C., Renström, E., Groop, L., Weng, J., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9121908 · Cited by 15
“Diabetes Study (UKPDS) and Diabetes Control and Complications Trial (DCCT), supports an association between glycemic control and cardiovascular disease (CVD) risk [1,2].”
Background
Reconstruction of the Cheek
Menick, F. J. (2001) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-200108000-00034 · Cited by 14
Comparison of two consecutive fat-rich and carbohydrate-rich meals on postprandial myeloperoxidase response in women with and without type 2 diabetes mellitus
Schindhelm, R. K., Alssema, M., Diamant, M., Teerlink, T., Dekker, J. M., Kok, A., Kostense, P. J., Nijpels, G., Heine, R. J., & Scheffer, P. G. (2008) · Metabolism · doi:10.1016/j.metabol.2007.09.010 · Cited by 14
“Patients with type 2 diabetes mellitus (DM2) have an increased risk of cardiovascular disease (CVD) [1-3].”
Background
Left ventricular diastolic dysfunction in asymptomatic type 2 diabetic patients: detection and evaluation by tissue Doppler imaging.
Zahiti, B., Gorani, D., Gashi, F. B., et al. (2013) · PubMed · doi:10.5455/aim.2013.21.120-123 · Cited by 14
“Some authors have reported a direct effect of diabetes on the myocardium (diabetic cardiomyopathy) that can lead to congestive heart failure in the absence of coronary atherosclerosis (9, 10, 11).”
Background
Evaluation of risk equations for prediction of short-term coronary heart disease events in patients with long-standing type 2 diabetes: the Translating Research into Action for Diabetes (TRIAD) study
Lu, S., Beckles, G. L., Crosson, J. C., Bilik, D., Karter, A. J., Gerzoff, R. B., Lin, Y., Ross, S. V., McEwen, L. N., Waitzfelder, B. E., et al. (2012) · BMC Endocrine Disorders · doi:10.1186/1472-6823-12-12 · Cited by 14
“Background Adults with diabetes have an increased risk of coronary heart disease (CHD) [1,2].”
Background
Sex differences in lipid profiles in relation to the progression of glucose abnormalities
Schianca, G. P. C., Fra, G. P., Colli, E., Bigliocca, M., Mella, R., Scaglia, E., & Bartoli, E. (2011) · Journal of Diabetes · doi:10.1111/j.1753-0407.2011.00160.x · Cited by 14
“Men have a higher incidence of cardiovascular disease (CVD) than women, but this difference disappears in individuals with type 2 diabetes mellitus (T2DM).(1,2) The magnitude of the diabetes-related cardiovascular risk is 50% higher in women,(3,4) although it varies between studies.”
Background
Rapid decline of renal function in patients with type 2 diabetes with heavy proteinuria: a report of three cases
Lim, C. T. S., Nordin, N. Z., Fadhlina, N. Z., et al. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1203-7 · Cited by 14
Comprehensive laboratory reference intervals for routine biochemical markers and pro‐oxidant‐antioxidant balance (PAB) in male adults
Ghazizadeh, H., Bohn, M. K., Zirak, R. G., Khodabandeh, A. K., Zare‐Feyzabadi, R., Saberi‐Karimian, M., Timar, A., Jaberi, N., Mohammadi‐Bajgiran, M., Sharifan, P., et al. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23470 · Cited by 14
The impact of diabetes duration on left ventricular diastolic function and cardiovascular disease
Kim, Y., Shin, M., Kim, Y. S., et al. (2012) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2011-130439 · Cited by 14
“DISCUSSION The main clinical findings of the our study are as follows: (1) there was a significant correlation between the duration of DM and the LV diastolic function, (2) the E/Ea and Ea/Aa ratios were the parameters that directly changed according to the duration of DM, (3) the duration of DM had less association w…”
BackgroundResult
Relation between age and coronary heart disease (CHD) risk in Asian Indian patients with diabetes: A cross-sectional and prospective cohort study
IDRIS, I. R., Deepa, R., Fernando, D., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.04.006 · Cited by 14
“[11] W.”
Background
Relationships of apolipoprotein B100 with the metabolic syndrome in Type 2 diabetes mellitus
Relimpio, F., Losada, F., Pumar, A., Mangas, M. Á., Morales, F., & Astorga, R. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00096-7 · Cited by 14
“Epidemiological studies have recognized hypercholesterolaemia [1] and diabetes [2–4] as independent risk factors for atherosclerotic cardiovascular disease in the general population.”
Background
A review of the efficacy of rosuvastatin in patients with type 2 diabetes
Tuomilehto, J. O., Leiter, L. A., & Kallend, D. G. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-504x.2004.00390.x · Cited by 14
Cardiovascular risk reduction in diabetes: underemphasised and overdue. Messages from major trials.
Adler, A. (2001) · Clinical medicine (London) · doi:10.7861/clinmedicine.1-6-472 · Cited by 15
Primary Prevention of Coronary Heart Disease
Ballantyne, C. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.6.6642-1 · Cited by 96
The heart in diabetes.
Kereiakes, D. J., Naughton, J., Brundage, B. H., & Schiller, N. B. (1984) · PubMed Central · Cited by 16
Traditional and disease-related cardiovascular risk factors in ANCA-associated vasculitis: A prospective, two-centre cohort study
Vegting, Y., Penne, E. L., Hilhorst, M. L., Hoekstra, T., Bemelman, F. J., Vogt, L., Voskuyl, A. E., Pagnoux, C., & Houben, E. (2023) · Joint Bone Spine · doi:10.1016/j.jbspin.2023.105540 · Cited by 13
Sex Differences in Lipid Profile across the Life Span in Patients with Type 2 Diabetes: A Primary Care-Based Study
Ambrož, M., de Vries, S. T., Vart, P., Dullaart, R. P. F., van Lennep, J. E. R., Denig, P., & Hoogenberg, K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081775 · Cited by 12
“In patients with type 2 diabetes (T2D), the risk of CVD is at least doubled in comparison to patients without diabetes [12,13].”
Background
Pulse pressure and systolic night–day ratio interact in prediction of macrovascular disease in patients with type 2 diabetes mellitus
Laugesen, E., Rossen, N. B., Poulsen, P. L., et al. (2011) · Journal of Human Hypertension · doi:10.1038/jhh.2011.9 · Cited by 13
Glyoxalase I and Aldose Reductase Gene Polymorphisms and Susceptibility to Carotid Atherosclerosis in Type 2 Diabetes
Wu, J., Li, X., Wang, J., Tang, J.-F., Wang, Y., & Peng, Y. (2011) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2010.0075 · Cited by 13
“I n patients with diabetes, the major cause of mortality and morbidity is cardiovascular disease (CVD), mainly due to markedly advanced atherosclerosis (Kannel et al. , 1979).”
Short-Term Low-Carbohydrate High-Fat Diet in Healthy Young Males Renders the Endothelium Susceptible to Hyperglycemia-Induced Damage, An Exploratory Analysis
Durrer, C. G., Lewis, N. C. S., Wan, Z., Ainslie, P. N., Jenkins, N. T., & Little, J. P. (2019) · Nutrients · doi:10.3390/nu11030489 · Cited by 13
“Impaired glucose tolerance and type 2 diabetes mellitus (T2DM) are associated with increased risk of cardiovascular disease (CVD; [1]) Accumulating evidence indicates that elevated postprandial hyperglycemia is an independent risk factor for CVD and cardiovascular mortality in individuals with, and without, T2DM [2].”
Background
Evaluation of Disease Complications Among Adults With Type 1 Diabetes and a Family History of Type 2 Diabetes in Taiwan
Lin, C.-H., Lo, F., Huang, Y., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.38775 · Cited by 13
Meta-analysis of the Effects of Paclitaxel-Eluting Stents Versus Bare Metal Stents on Volumetric Intravascular Ultrasound in Patients With Versus Without Diabetes Mellitus††Conflict of interest: Drs. Weissman, Dawkins, Grube, Ellis, and Cannon have received research grants from Boston Scientific Corporation. Drs. Mintz, Ellis, and Cannon are on the speaker's bureau of and have received honoraria from Boston Scientific Corporation. Drs. Ellis, Cannon, and Stone are consultants for and are on the advisory board of Boston Scientific Corporation. Drs. Mandinov and Baim have ownership interest or stock in and are employed at Boston Scientific Corporation.
Kimura, M., Mintz, G. S., Weissman, N. J., Dawkins, K. D., Grube, E., Ellis, S. G., Cannon, L., Masud, Z., Mandinov, L., Baim, D. S., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.12.025 · Cited by 13
Comparison of Bypass Surgery with Drug-Eluting Stents in Diabetic Patients with Left Main Coronary Stenosis
Zhao, X., Zhou, Y., Song, H., et al. (2011) · Yonsei Medical Journal · doi:10.3349/ymj.2011.52.6.923 · Cited by 13
“923 pISSN: 0513-5796, eISSN: 1976-2437 Yonsei Med J 52(6):923-932, 2011”
Screening for coronary artery disease in patients with diabetes: A Bayesian strategy of clinical risk evaluation and exercise echocardiography
Rakhit, D. J., Downey, M., Jeffriess, L., Moir, S., Prins, J. B., & Marwick, T. H. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.01.029 · Cited by 13
The relationship between cholelithiasis and diabetes mellitus: Discussion of age, obesity, hyperlipidemia and neuropathy.
Tanno, N., Koizumi, M., & Gotō, Y. (1988) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.154.11 · Cited by 13
7 Pathology of macrovascular disease
Ledet, T., Heickendorff, L., & Rasmussen, L. M. (1988) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(88)80039-9 · Cited by 13
Risk Factors of Cardiovascular Death in Diabetic Patients
Janeczko, D., Czyzyk, A., Kopczyński, J., & Krzyzanowski, M. (1991) · Diabetic Medicine · doi:10.1111/j.1464-5491.1991.tb02167.x · Cited by 13
Plasma levels of von Willebrand factor in non-insulin-dependent diabetes mellitus are influenced by dietary monounsaturated fatty acids
Thomsen, C., Rasmussen, O., Ingerslev, J., & Hermansen, K. (1995) · Thrombosis Research · doi:10.1016/0049-3848(95)93838-q · Cited by 13
Isoform Patterns of Apolipoprotein E in Diabetes Mellitus
Black, S. C., Hewett, S., Kotubi, Y., Brunt, R. V., & Reckless, J. P. D. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01437.x · Cited by 13
A gene therapy targeting medium-chain acyl-CoA dehydrogenase (MCAD) did not protect against diabetes-induced cardiac pathology
Weeks, K. L., Kiriazis, H., Wadley, G. D., Masterman, E. I., Sergienko, N. M., Raaijmakers, A. J. A., Trewin, A. J., Harmawan, C. A., Yildiz, G. S., Liu, Y., et al. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02397-2 · Cited by 12
“The Framingham Heart study [44], and subsequent meta-analysis [45], revealed that women with diabetes are more likely to develop heart failure or suffer a fatal cardiovascular event compared to men with diabetes.”
Structure–activity relationships for lipoprotein lipase agonists that lower plasma triglycerides in vivo
Caraballo, R., Larsson, M., Nilsson, S. K., Ericsson, M., Qian, W., Tran, N. P. N., Kindahl, T., Svensson, R., Saar-Kovrov, V., Artursson, P., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.08.058 · Cited by 12
Predicting domain-specific risk-taking attitudes of mainland China university students: a hyper core self-evaluation approach
Cheung, H. Y., Wu, J., & Tao, J. (2014) · Journal of Risk Research · doi:10.1080/13669877.2014.948903 · Cited by 12
“Studies have also found that adolescents who were involved in health and sexual risk taking had more illnesses and diseases (Baldwin and Baldwin 1988; Kannel and McGee 1979).”
Background
Sulfonylureas induce cholesterol accumulation in cultured human intimal cells and macrophages
Sobenin, I. A., Maksumova, M. A., Slavina, E. S., Balabolkin, M. I., & Orekhov, A. N. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90045-0 · Cited by 12
LIPID PROFILE OF CHILDREN WITH TYPE I DIABETES COMPARED TO CONTROLS
Imani, S. F., Hashemipour, M., & Kelishadi, R. (2010) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 12
Identification of a CYP19 Gene Single-Nucleotide Polymorphism Associated with a Reduced Risk of Coronary Heart Disease
Wang, B., Fu, Z.-Y., Ma, Y., Huang, D., Liu, F., Dong, C., Wang, T., & Meng, Y. J. (2015) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2015.0157 · Cited by 12
“, 1984), glucose (Kannel and McGee, 1979), triglyceride (Hulley et al.”
Background
Panvascular risk factor - Diabetes
Ramalingam, V., & Vijayvergiya, R. (2018) · Cor et Vasa · doi:10.1016/j.crvasa.2018.01.004 · Cited by 12
Hypotension after intensive care unit drop-off in adult cardiac surgery patients
Cengic, S., Zuberi, M., Bansal, V., et al. (2020) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v9.i2.20 · Cited by 12
Cost and co-morbidities associated with hypoglycemic inpatients in Belgium
Chevalier, P., Vandebrouck, T., Keyzer, D. D., Mertens, A. C., & Lamotte, M. (2015) · Journal of Medical Economics · doi:10.3111/13696998.2015.1086775 · Cited by 12
Triaging Women With Acute Coronary Syndrome
Kühn, L., Page, K., Davidson, P. M., & Worrall‐Carter, L. (2011) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e31820598f6 · Cited by 12
Association of gender with symptoms and complications in type II diabetes mellitus
Summerson, J. H., Spangler, J. G., Bell, R. A., et al. (1999) · Women s Health Issues · doi:10.1016/s1049-3867(98)00054-1 · Cited by 12
Prognostic value of myocardial perfusion scintigraphy in type 2 diabetic patients with mild, stable angina pectoris
Wiersma, J. J., Verberne, H. J., ten Holt, W. L., Radder, I. M., Dijksman, L. M., van Eck‐Smit, B. L. F., Trip, M. D., Tijssen, J. G. P., & Piek, J. J. (2009) · Journal of Nuclear Cardiology · doi:10.1007/s12350-009-9111-z · Cited by 12
Diabetic foot infection
Younes, N. A., & Bakri, F. G. (2006) · Saudi Medical Journal · doi:10.15537/1658-3175.3411 · Cited by 12
Melanocortin overexpression limits diet-induced inflammation and atherosclerosis in LDLR−/− mice
Nuutinen, S., Ailanen, L., Savontaus, E., & Rinne, P. (2018) · Journal of Endocrinology · doi:10.1530/joe-17-0636 · Cited by 14
Insulin, Indian origin and ischaemic heart disease
Hughes, L. O. (1990) · International Journal of Cardiology · doi:10.1016/0167-5273(90)90239-2 · Cited by 12
Effects of Atorvastatin on LDL sub‐fractions and peroxidation in type 1 diabetic patients: a randomised double‐blind placebo‐controlled study
Manuel‐y‐Keenoy, B., Campenhout, C. V., Vertommen, J., & Leeuw, I. D. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.402 · Cited by 12
“such as hypertension, obesity and dyslipidemia in these patients [1,2].”
Background
Preoperative risk evaluation in diabetic patients without angina
Bai, J., Hashimoto, J., Nakahara, T., Kitamura, N., Suzuki, T., & Kubo, A. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.03.013 · Cited by 12
Proteinuria as a Predictor of Total Plasma Homocysteine Levels in Type 2 Diabetic Nephropathy
Friedman, A. N., Hunsicker, L. G., Selhub, J., et al. (2002) · Diabetes Care · doi:10.2337/diacare.25.11.2037 · Cited by 12
Effects of a digital diabetes prevention program on cardiovascular risk among individuals with prediabetes
Michaud, T. L., Almeida, F. A., Porter, G. C., Kittel, C., Schwab, R. J., Brito, F. A., Wilson, K. E., Katula, J. A., Castro, C. M., Estabrooks, P. A., et al. (2023) · Primary care diabetes · doi:10.1016/j.pcd.2023.01.007 · Cited by 12
Prevention of coronary heart disease Part I. Primary prevention
Liesbon, P. R., & Amsterdam, E. A. (1999) · Disease-a-Month · doi:10.1016/s0011-5029(99)90016-0 · Cited by 11
Achieving lipid targets in adults with type 2 diabetes: The Stop Atherosclerosis in Native Diabetics Study
Russell, M., Silverman, A., Fleg, J. L., Lee, E. T., Méte, M., Weir, M. R., Wilson, C., Yeh, F., Howard, B. V., & Howard, W. J. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.07.007 · Cited by 11
Cutoff Values of Brachial-Ankle Pulse Wave Velocity for Atherosclerotic Risks by Age and Sex in the Japanese General Population
Mori, R., Miyata, M., Kubozono, T., Inadome, N., Kawasoe, S., Ojima, S., Kawabata, T., Salim, A. A., Miyahara, H., Tokushige, K., et al. (2022) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.63557 · Cited by 11
A long-term quality-of-care score for predicting the occurrence of macrovascular diseases in patients with type 2 diabetes mellitus
Li, P.-I., Wang, J.-N., & Guo, H. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.027 · Cited by 11
Elevated Glycated Albumin in Serum Is Associated with Adverse Cardiac Outcomes in Patients with Acute Coronary Syndrome Who Underwent Revascularization Therapy
Zhang, J., Du, Y., Hu, C., Liu, Y., Liu, J., Gao, A., Zhao, Y., & Zhou, Y. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.61358 · Cited by 10
Combining Population Health and Baseline Risk Strategy by Determining an Age Cutoff for Initiating Statins in Patients With Diabetes
Siyambalapitiya, S., Bulugahapitiya, U., Sithole, J., Song, S. H., Fernando, D. J. S., & IDRIS, I. R. (2007) · Diabetes Care · doi:10.2337/dc07-0439 · Cited by 11
“However, since predicted algorithms to calculate absolute risks have shown that age is the most important predictor of CVD events (8), we aimed to determine an appropriate age cutoff to prescribe statin therapy, taking into account various CVD prevention strategies.”
Background
Coping with Diabetes: Psychological Determinants of Diabetes Outcomes
Wagner, J. A., & Tennen, H. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-48670-3_11 · Cited by 11
CONTROL OF VASCULAR DISEASE IN PATIENTS WITH DIABETES MELLITUS
Ierardi, R. P., & Shuman, C. R. (1998) · Surgical Clinics of North America · doi:10.1016/s0039-6109(05)70321-2 · Cited by 11
Patients with type 2 diabetes: the case for primary prevention
Haffner, S. M. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00147-3 · Cited by 11
Diabetic emergencies: Part 1. Hypoglycaemia
Lewis, R. (1999) · Accident and Emergency Nursing · doi:10.1016/s0965-2302(99)80049-6 · Cited by 11
Intense Management of Diabetes Mellitus: Role of Glucose Control and Antiplatelet Agents
Mudaliar, S. R. D. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004263045 · Cited by 11
“Several epidemiologic studies indicate that men with diabetes mellitus are two to three times more likely to die from CVD than those without diabetes,(2-5) and women with diabetes face an even higher risk.(6,7) Diabetes not only increases the case-fatality rate of myocardial infarctions(8-10) but also increases prehos…”
Background
Physiologic Responses to Exercise in Older Women
Marks, B. L. (2002) · Topics in Geriatric Rehabilitation · doi:10.1097/00013614-200209000-00004 · Cited by 11
Multiple Roles of Palmitic Acid in Cardiovascular Diseases
Huan, J., Chen, N., Zhu, Y., Bi, Y., Yang, R., Yang, R., Yang, H., Niu, M., Huang, X., & Yang, J. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s530054 · Cited by 13
Impact of modifiable risk factors on prediction of 10-year cardiovascular disease utilizing framingham risk score in Southwest Iran
Saki, N., Babaahmadi‐Rezaei, H., Rahimi, Z., Raeisizadeh, M., Jorfi, F., Seif, F., Cheraghian, B., Ghaderi-Zefrehi, H., & Rezaei, M. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03388-4 · Cited by 10
“However, the impact is greater for women for cardiac failure and cardiovascular mortality [55].”
Background
The role of sRAGE in cardiovascular diseases
Delrue, C., Delanghe, J., & Speeckaert, M. M. (2023) · Advances in clinical chemistry · doi:10.1016/bs.acc.2023.08.005 · Cited by 10
Modeling heart failure risk in diabetes and kidney disease: limitations and potential applications of transverse aortic constriction in high-fat-fed mice
Tan, W., MULLINS, T. P., Flint, M., Walton, S. L., Bielefeldt‐Ohmann, H., Carter, D. A., Gandhi, M. R., McDonald, H. R., Li, J., Moritz, K. M., et al. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00357.2017 · Cited by 9
“Heart failure is one of the most common cardiovascular manifestations in type 2 diabetes mellitus (DM), with a two- to fivefold increased risk versus non-DM persons (21, 30, 35).”
Background
Benefits and harms of fibrate therapy in patients with type 2 diabetes: a systematic review and meta-analysis
Rodríguez‐Gutiérrez, R., García-Leal, M., Raygoza-Cortez, K., Flores-Rodríguez, A., Moreno-Alvarado, M., Heredia-Martínez, E. M., Vazquez-Baquerizo, B., Guerra-Espiricueta, R., Muñoz-Silva, V., & González‐González, J. G. (2023) · Endocrine · doi:10.1007/s12020-023-03401-y · Cited by 11
“Fibrate therapy in patients with T2D results in a marginal improvement of TGs and HDL-c but without reducing the risk of CV events and mortality.”
BackgroundInfluential
The AGE-RAGE axis in an Arab population: The United Arab Emirates Healthy Futures (UAEHFS) pilot study
Inman, C. K., AlJunaibi, A., Koh, H., Abdulle, A. M., Ali, R., Alnaeemi, A., Zaabi, E. A. A., Oumeziane, N., Bastaki, M. A., Al‐Houqani, M., et al. (2017) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2017.08.001 · Cited by 10
“The consequences of obesity include insulin resistance and the development of Type 2 diabetes mellitus, which are major causes of morbidity and mortality, on account of accelerated atherosclerosis, heart attacks and strokes [2,3].”
DPP-4 inhibition protects human umbilical vein endothelial cells from hypoxia-induced vascular barrier impairment
Hashimoto, N., Ikuma, K., Konno, Y., Hirose, M., Tadokoro, H., Hasegawa, H., Kobayashi, Y., & Takano, H. (2017) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2017.08.005 · Cited by 10
Coronary Atherosclerosis Assessment by Coronary CT Angiography in Asymptomatic Diabetic Population: A Critical Systematic Review of the Literature and Future Perspectives
Guaricci, A. I., Santis, D. D., Carbone, M., Muscogiuri, G., Guglielmo, M., Baggiano, A., Serviddio, G., & Pontone, G. (2018) · BioMed Research International · doi:10.1155/2018/8927281 · Cited by 10
Impact of hip fracture on all‐cause mortality in Japanese patients with type 2 diabetes mellitus: The Fukuoka Diabetes Registry
Komorita, Y., Iwase, M., Idewaki, Y., Fujii, H., Ohkuma, T., Ide, H., Jodai, T., Yoshinari, M., Murao‐Kimura, A., Oku, Y., et al. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13076 · Cited by 10
The complications of overweight and obesity according to obesity indicators (body mass index and waist circumference values) in a population of Tangier (northern Morocco): A cross-sectional study
Hamjane, N., Benyahya, F., Mechita, M. B., et al. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.07.033 · Cited by 10
Cardiovascular risk stratification in diabetic patients
Petretta, M., Acampa, W., Fiumara, G., & Cuocolo, A. (2013) · Clinical and Translational Imaging · doi:10.1007/s40336-013-0032-0 · Cited by 11
“Several epidemiological studies reported that diabetes is associated with a marked increase in the risk of coronary artery disease (CAD) [8–10].”
Background
Biochemical mechanism of insulin sensitization, lipid modulation and anti-atherogenic potential of PPAR α/γ dual agonist: Ragaglitazar
Sharma, S., Sowjanya, A., Kumari, M., Raichur, S., Gershome, C., Suresh, J., & Chakrabarti, R. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.09.009 · Cited by 10
Multimorbidity, the Predominant Predictor of Quality-of-Life, Following Successful Spinal Cord Stimulation for Angina Pectoris
Jitta, D. J., DeJongste, M. J. L., Kliphuis, C. M., et al. (2010) · Neuromodulation Technology at the Neural Interface · doi:10.1111/j.1525-1403.2010.00321.x · Cited by 10
Subclinical vascular alterations in young adults with type 1 diabetes detected by arterial tonometry
Barchetta, I., Sperduti, L., Germanò, G., et al. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1040 · Cited by 10
“Cardiovascular disease (CVD) accounts for a large proportion of morbidity and mortality [1] in patients with type 1 diabetes (T1D), and diabetes mellitus is a strong independent risk factor for the development of CVD in adults [2].”
Background
Ischaemic Heart Disease in South Indian NIDDM Patients - A Clinic Based Study on 6597 NIDDM Patients
Mohan, V., & Premalatha, G. (1995) · Cited by 10
Association between Non-HDL and HDL Cholesterol with microalbuminuria in patients with Diabetes
Aziz, K., & Al-Qahtani, M. (2013) · Journal of Diabetology · doi:10.4103/2078-7685.198103 · Cited by 10
Carotid Intima-Media Thickness in Patients with Diabetes Mellitus Attending Tertiary Care Hospital in Nigeria
Baba, M. M., Talle, M. A., Ibinaiye, P. O., et al. (2018) · Angiology Open Access · doi:10.4172/2329-9495.1000210 · Cited by 10
“The risk of clinical atherosclerotic diseases is increased by as much as two to three fold in the presence of diabetes mellitus [2,3].”
Background
Pharmacological Strategies to Reduce Cardiovascular Risk in Type 2 Diabetes Mellitus
Hovens, M. M. C., Tamsma, J. T., Beishuizen, E. D., & Huisman, M. V. (2005) · Drugs · doi:10.2165/00003495-200565040-00001 · Cited by 10
Will Sulfonylurea Treatment of Impaired Glucose Tolerance Delay Development and Complications of NIDDM?
Melander, A., Bitzén, P.-O., Sartor, G., Scherstén, B., & Wahlin‐Boll, E. (1990) · Diabetes Care · doi:10.2337/diacare.13.3.53 · Cited by 10
Abnormal glucose metabolism and features of the metabolic syndrome are common in patients presenting for elective cardiac catheterization
Harding, S. A., Anscombe, R., Weatherall, M., Prasad, S. B., Lever, N. A., & Krebs, J. D. (2006) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2006.01211.x · Cited by 10
Exploring new insights in coronary lesion assessment and treatment in patients with diabetes mellitus: the impact of optical coherence tomography
Hommels, T. M., Hermanides, R. S., Fabris, E., & Kedhi, E. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01844-1 · Cited by 10

Authors: Kannel, W. B., & McGee, D. L.
Venue: Diabetes Care
Publisher: American Diabetes Association
Published: 1979-03-01
Volume: 2
Issue: 2
Pages: 120-126
ISSN: 0149-5992 (ISSN-L)
1935-5548
DOI: 10.2337/diacare.2.2.120
OpenAlex: W2059537042
Cited by: 1,203
References: 0
Citations by year: 2026: 11 · 2025: 15 · 2024: 17 · 2023: 19 · 2022: 19 · 2021: 40 · 2020: 31 · 2019: 39 · 2018: 41 · 2017: 38 · 2016: 43 · 2015: 55 · 2014: 50 · 2013: 35 · 2012: 36
FWCI: 4.07
Type: journal article
Language: en
Open access: closed
Locations: Diabetes Care (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords: diabetes mellitus, impaired glucose tolerance, cardiovascular risk, coronary artery disease, peripheral vascular disease, stroke, cardiovascular mortality, heart failure, sex differences, cardiovascular risk factors, Framingham cohort
MeSH terms: Age Factors, Aged, Cardiovascular Diseases, Female, Glucose Tolerance Test, Humans, Male, Massachusetts, Middle Aged, Prospective Studies, Risk, Sex Factors, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cited by

Related

Metadata

Record

About these checks